Message from Management
Leadership Team
Fact Sheet
History
Kuvan®
Naglazyme®
Aldurazyme®
Clinical Development
Preclinical Development
Manufacturing
Sales and Marketing
Partnerships
BioMarin Corporate Campus
About BioMarin
•
Message from Management
•
Leadership Team
–
Management
–
Board of Directors
–
Science Advisory Board
•
Fact Sheet
•
History
Products
•
Kuvan®
•
Naglazyme®
•
Aldurazyme®
–
BioMarin/Genzyme LLC
Pipeline
•
Clinical Development
–
6R-BH
4
for Cardiovascular Indications
–
6R-BH
4
for Sickle Cell Disease
–
PEG-PAL for PKU
•
Preclinical Development
–
BMN-185 – IgA Protease
–
BMN-110 – ERT for MPS IVA
Business
•
Manufacturing
•
Sales and Marketing
•
Partnerships
Investors
•
Financial Information
•
Press Releases
•
SEC Filings
•
Corporate Governance
•
Investors' Kit
•
Calendar of Events
•
More Stock Information
Patients/Physicians
•
Lysosomal Storage Disorders
•
MPS I
•
MPS VI
•
PKU
•
Contact Patient/Physician Liaison
•
Resource Library
–
Patient Organizations
–
Professional Organizations
–
Publications
Careers
•
Why BioMarin
•
Benefits
•
Career Opportunities
Media
•
Fact Sheet
•
History
Contact Us
•
Directions/Map to Headquarters
•
Directions/Map to Manufacturing
Facility
Product Links
Legal Notice
Glossary
Back to Top
© 2006 BIOMARIN
LEGAL NOTICE
GLOSSARY
Last updated: 07/24/2008